Loiasis

11 clinical trials · Condition

Record	Firm	Date
Clinical Trial Evaluating the Safety and Efficacy of Moxidectin 2 mg Ivermectin-controlled in Loa Loa Microfilaremic Patients (NCT04049851)	Center for Research on Filariasis and Other Tropical Diseases, Cameroon	2022-04-07
Loiasis Cross-reactive Antigenemia and Treatment-related Adverse Events (NCT05085665)	Washington University School of Medicine	2021-07-30
Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients (NCT04049630)	Programme National de Lutte contre l'Onchocercose, Republic of the Congo	2021-01-16
Spontaneous Antigenemia in Loiasis (NCT04258670)	Washington University School of Medicine	2020-01-23
Efficacy and Microfilaricidal Kinetics of Imatinib for the Treatment of Loa Loa (NCT02644525)	National Institute of Allergy and Infectious Diseases (NIAID)	2019-09-16
Post-treatment Effects of Ivermectin (IVM) or Diethylcarbamazine (DEC) in Loiasis (NCT01593722)	National Institute of Allergy and Infectious Diseases (NIAID)	2012-04-01
Reslizumab to Prevent Post-treatment Eosinophilia in Loiasis (NCT01111305)	National Institute of Allergy and Infectious Diseases (NIAID)	2010-04-01

Every clearance here is in the API, with alerts when new ones post.